Higher SII and FAR levels associated with poorly-developed coronary collateral circulation in CTO patients.
This retrospective cohort analysis examined 469 patients with coronary chronic total occlusion who underwent elective coronary angiography. The study investigated the association between systemic immune-inflammation index (SII) and fibrinogen-to-albumin ratio (FAR) levels with the development of coronary collateral circulation (CCC). Patients were categorized based on whether they had well-developed or poorly-developed CCC.
In multivariate logistic regression analysis, SII levels were significantly higher in the poorly-developed CCC group compared to the well-developed CCC group. The odds ratio was 3.121 (95% CI: 1.827–5.537). Similarly, FAR levels were significantly higher in the poorly-developed CCC group, with an identical odds ratio of 3.121 (95% CI: 1.827–5.537).
No adverse events, serious adverse events, discontinuations, or tolerability data were reported in this analysis. The study design is observational, meaning causal inference cannot be made. Results are specific to patients with coronary chronic total occlusion undergoing elective coronary angiography and may not be generalizable to other populations or settings.
Clinicians should interpret these biomarkers as potential indicators of collateral development status in this specific patient population. Further prospective research is needed to validate these associations and determine clinical utility for risk stratification or therapeutic monitoring in chronic total occlusion management.